Search research articles
Contact Us
Filters
Showing results (81-90 of 113) with videos related to
Page
of 12
Sort By:
Cell Death & Disease
|
July 23, 2025
Proteasome inhibition overcomes resistance to targeted therapies in B-cell malignancy models and in an index patient
Johanne U Hermansen, Paschalis Athanasiadis, Yanping Yin, et al.
Blood Advances
|
February 7, 2019
Genome-wide promoter methylation of hairy cell leukemia
Alberto J Arribas, Andrea Rinaldi, Giorgia Chiodin, et al.
Neurologia
|
March 29, 2026
Six months of experience at a specialized daytime care center for people with amyotrophic lateral sclerosis (ALS) in the Community of Madrid
F J Martín-Sánchez, M C Marcos Sastre, E Muñoz de Maya, et al.
The Journal of Animal Ecology
|
September 3, 2024
Viviparity is associated with larger female size and higher sexual size dimorphism in a reproductively bimodal lizard
Evgeny S Roitberg, Hans Recknagel, Kathryn R Elmer, et al.
Oncogene
|
February 1, 2011
PI3K inhibition results in enhanced HER signaling and acquired ERK dependency in HER2-overexpressing breast cancer
V Serra, M Scaltriti, L Prudkin, et al.
British Journal of Haematology
|
November 27, 2023
The ATR inhibitor elimusertib exhibits anti-lymphoma activity and synergizes with the PI3K inhibitor copanlisib
Giulio Sartori, Chiara Tarantelli, Filippo Spriano, et al.
Acta Gastro-Enterologica Belgica
|
January 16, 2019
Prediction of the presence of esophageal varices using spleen stiffness measurement by transient elastography in cirrhotic patients
J Arribas Anta, M García González, M E Torres Guerrero, et al.
Oncogene
|
June 6, 2017
Pancreatic cancer heterogeneity and response to Mek inhibition
K Pedersen, F Bilal, C Bernadó Morales, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 23, 2022
Functional Testing to Characterize and Stratify PI3K Inhibitor Responses in Chronic Lymphocytic Leukemia
Yanping Yin, Paschalis Athanasiadis, Linda Karlsen, et al.
Haematologica
|
February 9, 2019
The novel CD19-targeting antibody-drug conjugate huB4-DGN462 shows improved anti-tumor activity compared to SAR3419 in CD19-positive lymphoma and leukemia models
Stuart W Hicks, Chiara Tarantelli, Alan Wilhem, et al.
Page
of 12
Search research articles
Search
Showing results (81-90 of 113) with videos related to
Sort By:
Page
of 12
Cell Death & Disease
|
July 23, 2025
Proteasome inhibition overcomes resistance to targeted therapies in B-cell malignancy models and in an index patient
Johanne U Hermansen, Paschalis Athanasiadis, Yanping Yin, et al.
Blood Advances
|
February 7, 2019
Genome-wide promoter methylation of hairy cell leukemia
Alberto J Arribas, Andrea Rinaldi, Giorgia Chiodin, et al.
Neurologia
|
March 29, 2026
Six months of experience at a specialized daytime care center for people with amyotrophic lateral sclerosis (ALS) in the Community of Madrid
F J Martín-Sánchez, M C Marcos Sastre, E Muñoz de Maya, et al.
The Journal of Animal Ecology
|
September 3, 2024
Viviparity is associated with larger female size and higher sexual size dimorphism in a reproductively bimodal lizard
Evgeny S Roitberg, Hans Recknagel, Kathryn R Elmer, et al.
Oncogene
|
February 1, 2011
PI3K inhibition results in enhanced HER signaling and acquired ERK dependency in HER2-overexpressing breast cancer
V Serra, M Scaltriti, L Prudkin, et al.
British Journal of Haematology
|
November 27, 2023
The ATR inhibitor elimusertib exhibits anti-lymphoma activity and synergizes with the PI3K inhibitor copanlisib
Giulio Sartori, Chiara Tarantelli, Filippo Spriano, et al.
Acta Gastro-Enterologica Belgica
|
January 16, 2019
Prediction of the presence of esophageal varices using spleen stiffness measurement by transient elastography in cirrhotic patients
J Arribas Anta, M García González, M E Torres Guerrero, et al.
Oncogene
|
June 6, 2017
Pancreatic cancer heterogeneity and response to Mek inhibition
K Pedersen, F Bilal, C Bernadó Morales, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 23, 2022
Functional Testing to Characterize and Stratify PI3K Inhibitor Responses in Chronic Lymphocytic Leukemia
Yanping Yin, Paschalis Athanasiadis, Linda Karlsen, et al.
Haematologica
|
February 9, 2019
The novel CD19-targeting antibody-drug conjugate huB4-DGN462 shows improved anti-tumor activity compared to SAR3419 in CD19-positive lymphoma and leukemia models
Stuart W Hicks, Chiara Tarantelli, Alan Wilhem, et al.
Page
of 12